https://www.selleckchem.com/pr....oducts/Vorinostat-sa
01; OR for hypo-HDL=0.168, 95% CI 0.030, 0.941; all were adjusted for confounders). Biological interaction between phenanthrol exposure and SOD reduction was linked to dyslipidemia risk (RERI=2.783, AP=0.498, S=2.537). Children with both risk factors (higher ∑ OH-Phes and lower SOD) had 5.594-times (95% CI 1.119, 27.958) the dyslipidemia risk than children with neither risk factors (lower ∑ OH-Phes and higher SOD). High PAH exposure combined with SOD reduction is recommended for predicting elevated risk for pediatric dyslipidemi